Annual Congress Glasgow 2004

Saturday, 04.09.2004
Sunday, 05.09.2004
Monday, 06.09.2004
Tuesday, 07.09.2004
Wednesday, 08.09.2004

Citations should be made in the following way: Authors. Title. Eur Respir J 2004; 24: Suppl. 48, abstract number.

Material from 2004:

3888 Abstracts
555 Slide presentations
20 Webcasts
96 Handouts

Material from 2004: Show

New and emerging pharmacological strategies in the treatment of asthma

Poster Discussion
Chairs: I. M. Adcock (London, United Kingdom), L. Bjermer (Lund, Sweden)

Download all media

UR-13484, an orally active small molecule VLA-4 inhibitor that reduces lung inflammation J. Alfón, E. González, A. Motos, R. Rosa, L. A. Gómez, M. Merlos, E. Carceller, J. Cortijo, E. Morcillo (Palau-solità i Plegamans, Valencia, Spain)
Effects of MAPK inhibitors on H₂O₂-induced IL-8 production and cell death in primary cultures of human bronchial epithelial cells G. Pelaia, G. Cuda, A. Vatrella, L. Gallelli, D. Fratto, V. Gioffrè, M. G. Matera, B. D‘Agostino, M. Caputi, M. Cazzola, R. Maselli, F. Rossi, F. S. Costanzo, S. A. Marsico (Catanzaro, Naples, Italy)
Peroxynitrite and superoxide anion chemiluminescence generation during human neutrophil respiratory bursts is reduced by a synergistic combination of budesonide and the SH metabolite of erdosteine M. Dal Sasso, M. Culici, P. C. Braga (Milan, Italy)
Inhibition of LPS-induced neutrophil recruitment in the lungs correlates with modulation of neutrophil CD11b expression using the selective CXCR2 receptor antagonist SB-656933 M. Salmon, D. C. Carpenter, C. J. Dehaas, R. Tal-Singer, H. M. Sarau, D. C. Underwood (King of Prussia, United States Of America)
The selective CXCR2 receptor antagonist SB-656933 inhibits CXCL1-induced neutrophil CD11b expression in human whole blood D. C. Carpenter, W. L. Rumsey, J. Busch-Petersen, H. M. Sarau, M. Salmon (King of Prussia, United States Of America)
NGF activation of the TrkA receptor induces airway smooth muscle proliferation V. Freund, C. Bertrand, C. Zuany, N. Frossard (Illkirch, Fresnes, France)
Effect of AVE5883, a dual NK1/NK2 receptor antagonist, on airway responsiveness to neurokinin A in asthma Z. Diamant, S. De Haas, J. Cohen, J. Burggraaf, R. Schoemaker, P. J. Sterk, S. Millet, C. Roy, B. Miller, R. Krishna, A. F. Cohen (Leiden, The Netherlands; Vitry sur Seine, France; Bridgewater, United States Of America)
*H₂S excites guinea pig bronchus via* TRPV1 activation** S. Harrison, P. Nicoletti, D. Gazzieri, M. Trevisani, P. Geppetti (Ferrara, Florence, Italy)
The benefit of new antileukotriene derivatives on airway responsiveness in ovalbumin-sensitized rats C. Bunu, G. Tanasie, L. Noveanu, M. Nechifor, M. Kuchar (Timisoara, Iasi, Romania; Prague, Czech Republic)
*Promotion of apoptosis of jurkat and HL-60 cells by the extracts of seabuckthorn (hippophae rhamnoides) seeds* Y. Kizawa, M. Furuya, K. Saito, S. Kitanaka, T. Kusama (Funabashi, Japan)
Inhibition of human neutrophil elastase activity by essential oil extracted from nigella sativa R. Kacem, N. Belattar, F. Buhling, W. Tobias, Z. Meraihi (Setif, Connstantine, Algeria; Magdeburg, Germany)
Possible impact of serum IgE variability on dose calculation of omalizumab (anti-IgE) J. Beier, K. M. Beeh, N. Beike, R. Buhl (Wiesbaden, Mainz, Germany)
Omalizumab added to best standard care reduces exacerbations in patients with severe persistent asthma according to GINA 2002 classification J. Bousquet, G. Ayre, M. Blogg (Montpellier, France; Horsham, United Kingdom)
The pharmacological and safety profile of a novel selective phosphodiesterase-4(PDE4) inhibitor:- GRC- 3886 S. K. V. S. Vakkalanka, G. Balasubramaniam, L. A. Gharat, V. D. Joshi, R. Hussain, N. Joshi, S. Rao, C. Page (Navi Mumbai, India; London, United Kingdom)
The non-glucocorticosteroid EPI-12323 attenuates acute allergen LAR and improves symptomotology in mild asthmatics F. Kanniess, J. Beier, R. J. Jordan, H. A. Ball, C. B. Robinson (Grosshansdorf, Mainz, Germany; Cranbury, United States Of America)
The bronchoprotective effects of levocetirizine on adenosine monophosphate challenge in patients with atopic asthma D. K. C. Lee, B. J. Lipworth (Dundee, United Kingdom)
Anti-inflammatory effects of histamine H₁-receptor antagonist and leukotriene CysLT₁-receptor antagonist in patients with atopic asthma maintained on inhaled corticosteroids D. K. C. Lee, B. J. Lipworth (Dundee, United Kingdom)
Clinical improvements in patients with latex - induced asthma treated with RuzamÔ G. Kazakova, O. Vasilyeva, N. Kolganova (Moscow, Russia)
Bronchial asthma as neurogenic paroxysmal disease - high effectiveness of carbamazepine in asthma monotherapy M. Lomia, Z. Chapichadze, M. Pruidze (Tbilisi, Georgia)
Efficacy of tulobuterol tape in adult patients with bronchial asthma Y. Sano, G. Tamura, K. Hirata, S. Ishioka, T. Miyamoto (Tokyo, Japan)